BRCA1/2 Flu Vaccine

Clinical trial NCT04499534 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04499534
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

BRCA1 Mutation BRCA2 Mutation

Start date: 2019-10-28
Primary completion: 2027-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.